<p>Distant-acting enhancers are central to human development<sup><CitationRef CitationID="CR1">1</CitationRef></sup>. However, our limited understanding of their functional sequence features prevents the interpretation of enhancer mutations in disease<sup><CitationRef CitationID="CR2">2</CitationRef></sup>. Here we determined the functional sensitivity to mutagenesis of human developmental enhancers in vivo. Focusing on seven enhancers that are active in the developing brain, heart, limb and face, we created over 1,700 transgenic mice for over 260 mutagenized enhancer alleles. Systematic mutation of 12-base-pair blocks collectively altered each sequence feature in each enhancer at least once. We show that 69% of all blocks are required for normal in vivo activity, with mutations more commonly resulting in loss (60%) than in gain (9%) of function. Using predictive modelling, we annotated critical nucleotides at the base-pair resolution. The vast majority of motifs predicted by these machine learning models (88%) coincided with changes in in vivo function, and the models showed considerable sensitivity, identifying 59% of all functional blocks. Taken together, our results reveal that human enhancers contain a high density of sequence features that are required for their normal in vivo function and provide a rich resource for further exploration of human enhancer logic.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

In vivo mapping of mutagenesis sensitivity of human enhancers

  • Michael Kosicki,
  • Boyang Zhang,
  • Vivian Hecht,
  • Anusri Pampari,
  • Laura E. Cook,
  • Neil Slaven,
  • Jennifer A. Akiyama,
  • Ingrid Plajzer-Frick,
  • Catherine S. Novak,
  • Momoe Kato,
  • Stella Tran,
  • Riana D. Hunter,
  • Kianna von Maydell,
  • Sarah Barton,
  • Erik Beckman,
  • Yiwen Zhu,
  • Diane E. Dickel,
  • Anshul Kundaje,
  • Axel Visel,
  • Len A. Pennacchio

摘要

Distant-acting enhancers are central to human development1. However, our limited understanding of their functional sequence features prevents the interpretation of enhancer mutations in disease2. Here we determined the functional sensitivity to mutagenesis of human developmental enhancers in vivo. Focusing on seven enhancers that are active in the developing brain, heart, limb and face, we created over 1,700 transgenic mice for over 260 mutagenized enhancer alleles. Systematic mutation of 12-base-pair blocks collectively altered each sequence feature in each enhancer at least once. We show that 69% of all blocks are required for normal in vivo activity, with mutations more commonly resulting in loss (60%) than in gain (9%) of function. Using predictive modelling, we annotated critical nucleotides at the base-pair resolution. The vast majority of motifs predicted by these machine learning models (88%) coincided with changes in in vivo function, and the models showed considerable sensitivity, identifying 59% of all functional blocks. Taken together, our results reveal that human enhancers contain a high density of sequence features that are required for their normal in vivo function and provide a rich resource for further exploration of human enhancer logic.